<DOC>
	<DOCNO>NCT00299455</DOCNO>
	<brief_summary>This prospective , randomize , double-blind , placebo control one-center study carry primary care set health center City Turku , Finland . The study patient allocate one two parallel treatment group ( amoxicillin-clavulanate placebo ) . The hypothesis symptom sign acute otitis medium resolve effectively antimicrobial treatment placebo . Furthermore , study aim find prognostic factor could help direct antimicrobial treatment correct subgroup young patient .</brief_summary>
	<brief_title>Amoxicillin Clavulanate Treatment Acute Otitis Media</brief_title>
	<detailed_description />
	<mesh_term>Otitis</mesh_term>
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Acute otitis medium Age 6 35 mo Spontaneous perforation tympanic membrane drainage Systemic nasal corticosteroid therapy within 3 precede day Antihistamine therapy 3 preceding day Oseltamivir therapy within 3 precede day Allergy amoxicillin/penicillin Tympanostomy tube present tympanic membrane Clinical evidence infection require systemic antimicrobial treatment Documented Ebstein Barr virus infection within 7 precede day Down syndrome condition affect middle ear infection Known immunodeficiency Vomiting another symptom violate per oral dosage Poor parental cooperation due language reason Use investigational drug 4 preceding week</criteria>
	<gender>All</gender>
	<minimum_age>6 Months</minimum_age>
	<maximum_age>35 Months</maximum_age>
	<verification_date>February 2009</verification_date>
</DOC>